Lexicon plans to raise $95 million
09 March 2010
Eleanor Malone
eleanor.malone@informa.com
Lexicon Pharmaceuticals has announced plans to offer for sale $95 million of its common stock in an underwritten public offering. It could also sell up to $14.25 million worth of shares as an over-allotment option.
Lexicon expects net proceeds from the basic offering of around $89 million....
Please Login to read the full article.